A Company Dedicated to Scientific innovation
Eisai is a company rooted in scientific innovation. To better position us to continue delivering novel therapies, all our drug discovery efforts are aligned around what we called “Deep Human Biology Learning”, in which our scientists focus on harnessing the combined power of human genetics, data sciences and precision chemistry. The path to progress in treating cancers and neurodegenerative diseases like Alzheimer’s is neither straightforward nor quick, requiring an unwavering focus and longstanding commitment. Our four decades of research in Alzheimer’s disease and difficult-to-treat cancers demonstrate we will never give up until our purpose is achieved.
From the research and development of symptomatic breakthrough treatment in the 1980s and 1990s, to our investigational anti-amyloid protofibril antibody and anti-MTBR tau antibody in late-stage clinical development, Eisai stands at the forefront of Alzheimer’s research. We are determined to identify the root cause and stage of each person’s disease so that we may provide the right intervention including prevention, for the right person, at the right time. We at Eisai are not only dedicated to delivering therapies for Alzheimer’s disease, but also committed to simplifying the patient journey, such as simple blood tests to diagnose Alzheimer’s disease, and supporting multi-disciplinary solutions to improve the lives of people living with Alzheimer’s disease and their care partners and families.
In oncology, we distill the meaningful time spent with people living with cancer into a motivation that drives the mindset we bring to our daily work. Understanding these experiences fuels our successful development of life-changing therapies for multiple cancer types, as well as the design of impactful and relevant support programs. Cancers evolve as better treatments are being introduced, and we at Eisai are devoted to stay in front of these difficult-to-treat cancers. Patients push their limits to live full lives despite their cancer, so it's the wonderful duty of each Eisai employee to honor that strength and give no less than everything we have.